Growth Metrics

Corbus Pharmaceuticals Holdings (CRBP) Depreciation and Depletion (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Depreciation and Depletion over the past 7 years, most recently at $100000.0 for Q4 2023.

  • For Q4 2023, Depreciation and Depletion fell 45.77% year-over-year to $100000.0; the TTM value through Dec 2023 reached $681870.0, down 10.63%, while the annual FY2024 figure was $600000.0, 0.0% changed from the prior year.
  • Depreciation and Depletion for Q4 2023 was $100000.0 at Corbus Pharmaceuticals Holdings, down from $200000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $320188.0 in Q2 2020 and troughed at $100000.0 in Q4 2023.
  • A 4-year average of $223054.4 and a median of $201039.5 in 2020 define the central range for Depreciation and Depletion.
  • Biggest five-year swings in Depreciation and Depletion: increased 26.82% in 2021 and later tumbled 45.77% in 2023.
  • Year by year, Depreciation and Depletion stood at $282245.0 in 2020, then decreased by 26.35% to $207868.0 in 2021, then dropped by 11.29% to $184402.0 in 2022, then tumbled by 45.77% to $100000.0 in 2023.
  • Business Quant data shows Depreciation and Depletion for CRBP at $100000.0 in Q4 2023, $200000.0 in Q3 2023, and $200000.0 in Q2 2023.